A Medicare Advantage plan is dropping Boston's top cancer hospital on October 1 — and 250 people are mid-treatment
Mass General Brigham's own Medicare Advantage plan is removing Dana-Farber Cancer Institute from its network two weeks before Medicare's fall enrollment window opens. About 20,500 members are affected, roughly 250 of them in active chemotherapy or radiation. The plan blames federal reimbursement. The patients blame a corporate divorce. Here is what the rules actually give you if this happens to your plan.
Eldon Clingan is 88, a retired accountant, and has had the same oncologist at Dana-Farber Cancer Institute for more than 23 years. He credits her with saving his life. On October 1, according to the Boston Globe, which broke the story on Thursday, his Medicare Advantage plan will stop counting her as in-network.
The plan is run by the insurance arm of Mass General Brigham, the largest health system in Massachusetts. It has about 20,500 Medicare Advantage members. Roughly 1,000 of them had or have appointments at Dana-Farber this year, and about 250 are in active treatment there right now — chemotherapy, radiation, the kind of care you do not pause to shop for a new doctor.
"It only makes sense in terms of this war that is going on," Clingan told the Globe, referring to the very public split between Mass General Brigham and Dana-Farber. "I feel like I'm collateral damage." His wife, Carol, was more specific about the stakes: one of his medications runs about $10,000 a month. "It could bankrupt us if we can't get coverage for the medicine."
- October 1, 2026 — the date Dana-Farber leaves the network of Mass General Brigham's Medicare Advantage plan
- 20,500 Medicare Advantage members in the plan; about 1,000 had or have Dana-Farber appointments this year; about 250 are in active cancer treatment there
- 90 days — the continuity-of-care window the plan is offering, or through the end of a current treatment plan; longer for chemotherapy, radiation, cell therapy and clinical trials
- 5% — Medicare Advantage's share of the plan's 400,000-plus insured members
- 11 — the number of cancer hospitals nationwide with the special Medicare designation that pays them more, Dana-Farber among them
- 55% of eligible Medicare beneficiaries are in a Medicare Advantage plan in 2026 — more than 35 million people
- October 15 to December 7 — Medicare's annual enrollment period, when anyone can switch plans for January 1
(Sources: The Boston Globe, September 4, 2026; STAT; Dana-Farber Cancer Institute; Mass General Brigham Health Plan; KFF, Medicare Advantage in 2026; Medicare.gov.)
What the plan says, and what it does not say
Mass General Brigham Health Plan's explanation is money. In a statement to the Globe it described a "challenging environment" in which Medicare Advantage plans face inadequate federal reimbursements, and said the decision was "not related to any discussions, agreements, or activities between" the two health systems.
The money part is real. Dana-Farber is one of only 11 cancer hospitals in the country that Medicare exempts from its standard inpatient payment system, a designation created in the 1980s for centers treating unusually complex cancer patients. It means Medicare — and by extension a Medicare Advantage plan mimicking Medicare's rates — pays Dana-Farber more than it pays a general hospital for the same care. If your insurer wants to trim its most expensive line item, the most expensive hospital is where you look.
The "not related" part is harder to take at face value. Dana-Farber and Mass General Brigham are in the middle of a slow-motion divorce. Dana-Farber has provided inpatient cancer care for Mass General Brigham's network for decades; that partnership ends in 2028. Dana-Farber is building a new cancer hospital with Beth Israel Lahey Health, Mass General Brigham's chief rival, and Mass General Brigham has announced a $400 million investment in its own cancer institute. Cutting Dana-Farber out of the insurance network two years early may be financially motivated. It is also, conveniently, exactly what you would do if you wanted your members' cancer care to stay in the family.
"Why would you do that to patients?" asked David E. Williams of the consultancy Health Business Group, speaking to the Globe. "If you're trying to be a good health plan, why would you go and say you suddenly can't have access to the top cancer center in Boston?"
Dana-Farber's statement was one sentence long and aimed squarely at the plan: "Dana-Farber's primary concern is continuity of care for our patients."
Why this is a Medicare Advantage story, not a Boston story
Original Medicare has no network. Any doctor who takes Medicare is your doctor, in any state. Medicare Advantage — the private-plan version, now covering 55% of eligible beneficiaries, more than 35 million people, according to KFF — trades that freedom for a network in exchange for lower premiums and extras like dental or gym benefits.
The catch is written into the deal but rarely read aloud: the network can change, and it can change mid-year. Plans are allowed to drop providers with notice to members. You, the member, are locked into the plan until the next enrollment window. The insurer gets an exit; you get a letter.
Mass General Brigham's timing makes the letter slightly less cruel than it could have been. Dana-Farber leaves the network on October 1. Medicare's annual enrollment period opens October 15 and runs through December 7, and changes made in that window take effect January 1. So the gap between "your oncologist is out of network" and "you can pick a plan that covers her" is two weeks — and the plan's continuity-of-care terms are meant to bridge it. The gap between that and "the new plan actually starts" is three months.
And it lands on the population that needs cancer care most. Between 2019 and 2023, people aged 65 to 74 were diagnosed with cancer at more than three times the rate of people aged 40 to 64. A Medicare plan without a top cancer center is not missing a niche benefit. It is missing the benefit.
What the 250 actually get
Members in active treatment at Dana-Farber keep in-network coverage there for 90 days after October 1, or through the completion of their current treatment plan. For patients in chemotherapy, radiation, cell therapy or a clinical trial, the plan says that window can extend into next year.
Read that carefully, because "current treatment plan" is a phrase that will be interpreted by the insurer, not by you. A course of radiation with a defined end date is a treatment plan. Maintenance therapy for a chronic cancer that a patient has managed for two decades — Eldon Clingan's situation — is a much fuzzier thing. If your oncologist writes "ongoing" on the form, expect the plan to ask what that means.
Roughly 750 other members who saw a Dana-Farber doctor this year but are not mid-treatment get nothing special. Their next visit after October 1 is out of network, and on a Medicare Advantage HMO that typically means not covered at all.
What to actually do if this is your plan — or your parent's
Get the continuity-of-care terms in writing, now. Call the plan, ask for the exact end date of your in-network coverage at Dana-Farber, and ask what documentation your oncologist needs to submit to extend it. Dana-Farber's financial counselors can be reached at 617-582-9820 and are, right now, doing exactly this for other patients.
Ask about a special enrollment period. Medicare can grant a special enrollment period when a plan makes a significant mid-year change to its provider network. It is at the government's discretion, not automatic — but a 20,500-member plan dropping the region's only specially designated cancer hospital is the kind of change the rule was written for. Call 1-800-MEDICARE and ask, and call your State Health Insurance Assistance Program, which in Massachusetts is called SHINE and is free.
Use the fall window, and compare on the doctor, not the premium. From October 15, look up every plan in your county on Medicare.gov's Plan Finder and check whether your specific oncologist — by name, at Dana-Farber's Longwood address — is in network for 2027. Do not trust a directory that says "Dana-Farber" is covered; directories are wrong often enough that we wrote a guide about ghost networks. Call the doctor's office and ask which plans they will accept in January.
Consider going back to Original Medicare. No network, any oncologist who takes Medicare, no referral fights. The price is the 20% coinsurance with no cap, which is why most people pair it with a Medigap supplement. Normally, switching back after your first year means Medigap insurers can charge you more or turn you down for health reasons. Massachusetts is one of the few states where they cannot — Medigap plans there must accept you regardless of health, year-round. If you are in a different state, your rights are narrower; our Medigap guide walks through the trial-right exceptions, and this comparison lays out the trade-off honestly.
Do not pay an out-of-network bill without appealing. If a Dana-Farber claim is denied after October 1 while you believe you are inside the continuity window, appeal in writing and ask the plan to cite the exact term it is applying. Medicare Advantage appeals have deadlines and five levels; the first one is often enough when the plan's own letter promised you coverage.
The bigger pattern
Mass General Brigham is not the first Medicare Advantage insurer to drop a marquee hospital, and hospitals have been dropping Medicare Advantage plans too, citing slow payment and denied claims. Both sides describe a "challenging environment." Neither side's challenge is the one faced by an 88-year-old man deciding, in the two weeks before October 15, whether to keep his oncologist or his insurance.
Medicare Advantage sells you a network as a feature. This week it reminded 20,500 people that the network belongs to the plan, and the plan can take it back whenever the math says so.